Αποτελέσματα Αναζήτησης
Methergine. Pre-Administration Assessment: Post Administration Evaluation: Nursing Considerations: Can cause hypertension, cramps, nausea, vomiting, dyspnea. Monitor BP, heart rate, uterine response. Assess calcium levels – effectiveness ↓ with hypocalcemia. Monitor uterine bleeding and notify physician of any changes.
Interventions. Because of the risk of hypertension and arrhythmias, use caution during aerobic exercise and other forms of therapeutic exercise. Assess exercise tolerance frequently (BP, heart rate, respiration, fatigue levels), and terminate exercise immediately if any untoward responses occur (see Appendix L).
Methylergonovine. This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.
24 Ιαν 2018 · Methergine (Maternal) Drug Study. Availability Tablets: 200 mcg (0.2 mg). Injection: 200 mcg (0.2 mg)/ml in 1-ml ampules. Methylergonovine maleate (methergine) is an ergot alkaloid that stimulates smooth muscle tissue.
Abstract. Background: Maternal death from postpartum hemorrhage is a key maternal health indicator and directly reflects the care provided during the intrapartum and postpartum periods. The aim is...
Nursing Considerations. • can cause hypertension, cramps, nausea, vomiting, dyspnea. • monitor BP, heart rate, uterine response. • assess calcium levels – effectiveness ↓ with hypocalcemia. • monitor uterine bleeding and notify physician of any changes.
31 Οκτ 2018 · Thirty postpartum women were given methylergonovine 0.2 mg orally 3 times daily for the first 7 days postpartum. Baseline (prior to nursing) serum prolactin was no different from those of 30 postpartum women who received no methylergonovine on days 1 and 3 postpartum.
